[Skip to Content]
Provided by ASME The American Society of Mechanical Engineers
Banner
FEDSM2026
Hyatt Regency Bellevue, Bellevue WA, USA
Conference: July 26-29, 2026
Menu
  • Policies
    • Conflict in Ukraine
    • Code of Conduct/Anti-Harassment
    • Confirm Co-Authorship
    • Presentation Requirements
    • Artificial Intelligence
  • Help
    • Contact Us
    • Author Resources
      • ASME Presenter Attendance Policy
      • ASME Plagiarism Screening (iThenticate)
      • Full-length Paper Preparation
      • Conference-Specific Information and Templates
      • Copyright Transfer Form
      • Technical Presentation Tips
      • Indexing
      • Author FAQS
      • Submission Types
    • Organizer Resources
    • Help Desk Calls
    • Webtool Feedback And Feature Requests
  • Publication Schedule
  • Event Site
  • My Account
  • Home
  • Home
  • ASME 2021 Fluids Engineering Division Summer Meeting (FEDSM2021) Session Gallery
  • 06-03-02 Biologically Enabled Microfluidics and Biomicrofluidics
  • A Microfluidic Platform for On-Chip Analysis of Circulating Tumor Cells

Session: 06-03-02 Biologically Enabled Microfluidics and Biomicrofluidics

Paper Number: 65766

Start Time: August 11th, 10:50 AM

65766 - A Microfluidic Platform for On-Chip Analysis of Circulating Tumor Cells 

Studies have shown that primary tumor sites begin shedding cancerous cells into peripheral blood at early stages of cancer, and the presence and frequency of circulating tumor cells (CTCs) in blood is directly proportional to disease progression. The challenge is that the concentration of the CTCs in peripheral blood may be extremely low. In the past few years, several microfluidic-based concepts have been investigated to isolate CTCs from whole blood. However, these devices are generally hampered by complex fabrication processes and very low volumetric throughputs, which may not be practical for rapid clinical applications. This paper presents a high-performance yet simple magnetophoretic microfluidic chip for the enrichment and on-chip analysis of rare CTCs from blood. Microscopic and flow cytometric assays developed for selection of cancer cell lines, selection of monoclonal antibodies, and optimization of bead coupling are discussed. Additionally, on-chip characterization of rare cancer cells using high resolution immunofluorescence microscopy and modeling results for prediction of CTC capture length are presented. The device has the ability to interface directly with on-chip pre and post processing modules such as mixing, incubation, and automated image analysis systems. These features will enable us to isolate rare cancer cells from whole blood and detect them on the chip with subcellular resolution.

Presenting Author: Jeff Darabi Southern Illinois University Edwardsville

Authors:

Jeff Darabi Southern Illinois University Edwardsville
Joseph Schober Southern Illinois University Edwardsville

A Microfluidic Platform for On-Chip Analysis of Circulating Tumor Cells

Category

Technical Paper Publication

This site supports all modern browsers, such as Chrome, Firefox, Safari, and Edge. Microsoft has announced it will no longer support IE 11 as of August 2021. If you prefer to or you are required to continue using a Microsoft browser, you can use Edge.

  • ASME.ORG
  • Press
  • Terms of Use
  • Privacy Statement
  • ASME Communication Preferences
  • Community Rules

© The American Society of Mechanical Engineers

Stay Connected